Financial Statements — SLGL
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 10.22 | 11.55 | 15.62 | 5.77 | 11.15 |
| Short-term Investments | 14.05 | 14.91 | 17.86 | 9.85 | 6.83 |
| Accounts Receivable | 10.04 | 6.06 | 2.21 | 10.18 | 0.96 |
| Total Current Assets | 36.26 | 38.28 | 51.59 | 48.48 | 41.39 |
| Property, Plant & Equipment | 0.16 | 0.31 | 0.57 | 0.83 | 1.40 |
| Total Non-current Assets | 3.05 | 3.72 | 3.51 | 6.51 | 5.01 |
| Total Assets | 39.31 | 42.01 | 55.10 | 54.98 | 46.41 |
| Accounts Payable | 1.17 | 0.68 | 0.46 | 0.86 | 1.35 |
| Total Current Liabilities | 4.96 | 5.20 | 5.67 | 3.23 | 5.16 |
| Total Non-current Liabilities | 2.47 | 1.90 | 1.14 | 1.41 | 2.00 |
| Total Liabilities | 7.43 | 7.10 | 6.81 | 4.63 | 7.16 |
| Retained Earnings | (228.08) | (224.67) | (209.76) | (183.87) | (193.46) |
| Total Stockholder Equity | 31.88 | 34.90 | 48.30 | 50.35 | 39.25 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Total Revenue | 17.26 | 5.43 | 0.59 | 3.52 | 0.90 |
| Research & Development | 4.65 | 2.44 | 5.31 | 2.38 | 6.93 |
| Selling, General & Admin | 1.39 | 1.37 | 1.81 | 1.60 | 2.04 |
| Operating Income | 11.23 | 1.62 | (6.53) | (0.46) | (8.04) |
| Net Income | 11.61 | 1.98 | (5.97) | (0.13) | (8.03) |
| Basic EPS | 4.17 | 0.07 | 0.22 | 0.01 | -- |
| Diluted EPS | 4.17 | 0.07 | 0.22 | 0.01 | -- |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | 0.60 | (7.63) | (8.34) | (6.54) | (11.37) |
| Capital Expenditures | 0.03 | 0.00 | 0.09 | 0.10 | 0.05 |
| Free Cash Flow* | 0.57 | (7.63) | (8.43) | (6.65) | (11.42) |
| Investing Cash Flow | (9.81) | 12.47 | (10.20) | (7.92) | 15.33 |
| Financing Cash Flow | 0.00 | 0.00 | 21.72 | 0.02 | 0.08 |
* Derived from reported values
